These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 16433886)

  • 1. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
    Jensen RT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the risk of iatrogenic hypergastrinaemia from patients with gastrinoma.
    Waldum H
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):3. PubMed ID: 16433885
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
    Delaney B; McColl K
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
    Hirschowitz BI; Haber MM
    Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
    Rauws EA
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
    Robinson M
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
    Hage E; Hendel L; Gustafsen J; Hendel J
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term acid control and proton pump inhibitors: interactions and safety issues in perspective.
    Freston JW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):51S-55S; discussion 55S-57S. PubMed ID: 9127627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance.
    Lamberts R
    Microsc Res Tech; 2000 Mar; 48(6):357-66. PubMed ID: 10738317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastro-oesophageal reflux disease and Helicobacter pylori or gastro-oesophageal reflux disease from Helicobacter pylori?
    Lundell L
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S23-7. PubMed ID: 11430505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia.
    Hirschowitz BI; Worthington J; Mohnen J; Haber M
    Aliment Pharmacol Ther; 2007 Sep; 26(6):869-78. PubMed ID: 17767471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of patients with Zollinger-Ellison syndrome.
    Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
    Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitors and Helicobacter pylori gastritis: friends or foes?
    Kuipers EJ
    Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):187-94. PubMed ID: 16930292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic duodenal bulb gastrin-cell tumors: association with Helicobacter pylori gastritis and long-term use of proton pump inhibitors.
    Merchant SH; VanderJagt T; Lathrop S; Amin MB
    Am J Surg Pathol; 2006 Dec; 30(12):1581-7. PubMed ID: 17122515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: the long-term use of proton-pump inhibitors.
    Raghunath AS; O'Morain C; McLoughlin RC
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():55-63. PubMed ID: 16042660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: Strategies to determine whether hypergastrinaemia is due to Zollinger-Ellison syndrome rather than a more common benign cause.
    Murugesan SV; Varro A; Pritchard DM
    Aliment Pharmacol Ther; 2009 May; 29(10):1055-68. PubMed ID: 19226290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin B12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitors.
    Hirschowitz BI; Worthington J; Mohnen J
    Aliment Pharmacol Ther; 2008 Jun; 27(11):1110-21. PubMed ID: 18315582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric carcinoids after long-term use of a proton pump inhibitor.
    Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
    Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.